Egetis Therapeutics

Major Shareholding Notification • May 20, 2022

Issuer Egetis Therapeutics AB (publ)

Holder

Flerie Invest AB

Instrument

BTA SE0017770027
4,350,594
4,350,594
Reason for major shareholding notification New share issue
17/05/2022
5 %
5 %
12,087,069
12,087,069
0
5.63266 %
5.63266 %
0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	5.63266 %	12,087,069
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled - Cash settled
Total	5.63266 %	12,087,069
Group total holdings Voting rights 12,087,069 Percentage of voting rights 5.63266
Published 20/05/2022 14:16
Contact
Name Cecilia Scheele Phone +46706006856 Email cecilia@flerie.com
CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25